Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Aug;50(8):674–676. doi: 10.1136/jcp.50.8.674

Biochemical assessment of pancreatic disease in human immunodeficiency virus infected men.

M R Hancock 1, N A Smith 1, D A Hawkins 1, B Gazzard 1, S G Ball 1
PMCID: PMC500116  PMID: 9301552

Abstract

AIM: To determine the usefulness of measuring amylase activity as an indicator of pancreatic disease in human immunodeficiency virus (HIV) positive patients. METHODS: A prospective study of 129 ambulant HIV positive males. Total amylase, pancreatic amylase, and lipase activities were assayed using commercial test kits on an automated analyser. Samples with raised amylase were examined for the presence of macroamylasaemia using cellulose acetate electrophoresis. RESULTS: Thirty six (28%) of the subjects had raised total amylase activities compared with healthy, age matched blood donors. However, almost half of these were because of an increase of the salivary fraction. Four subjects were found to have macroamylasaemia. Pancreatic amylase and lipase assays, more specific indicators of pancreatic disease, produced significantly fewer abnormal results. There was no association between abdominal symptoms and elevated enzyme levels. CONCLUSIONS: Total amylase is a poor indicator of pancreatic disease in HIV infected outpatients. Specific assays for pancreatic amylase offer advantages over the traditional total amylase assay. The lipase assay produced the least number of abnormal results and its use could improve the biochemical identification of patients with possible pancreatic disease and allow a more selective investigation of these cases.

Full text

PDF
674

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apple F., Benson P., Preese L., Eastep S., Bilodeau L., Heiler G. Lipase and pancreatic amylase activities in tissues and in patients with hyperamylasemia. Am J Clin Pathol. 1991 Nov;96(5):610–614. doi: 10.1093/ajcp/96.5.610. [DOI] [PubMed] [Google Scholar]
  2. Brivet F. G., Naveau S. H., Lemaigre G. F., Dormont J. Pancreatic lesions in HIV-infected patients. Baillieres Clin Endocrinol Metab. 1994 Oct;8(4):859–877. doi: 10.1016/s0950-351x(05)80306-4. [DOI] [PubMed] [Google Scholar]
  3. Butler K. M., Venzon D., Henry N., Husson R. N., Mueller B. U., Balis F. M., Jacobsen F., Lewis L. L., Pizzo P. A. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics. 1993 Apr;91(4):747–751. [PubMed] [Google Scholar]
  4. Clavien P. A., Robert J., Meyer P., Borst F., Hauser H., Herrmann F., Dunand V., Rohner A. Acute pancreatitis and normoamylasemia. Not an uncommon combination. Ann Surg. 1989 Nov;210(5):614–620. doi: 10.1097/00000658-198911000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greenberg R. E., Bank S., Singer C. Macroamylasaemia in association with the acquired immunodeficiency syndrome. Postgrad Med J. 1987 Aug;63(742):677–679. doi: 10.1136/pgmj.63.742.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lambertus M. W., Anderson R. E. Hyperamylasemia in patients with human immunodeficiency virus infection. N Engl J Med. 1990 Dec 13;323(24):1708–1709. doi: 10.1056/NEJM199012133232416. [DOI] [PubMed] [Google Scholar]
  7. Lott J. A., Patel S. T., Sawhney A. K., Kazmierczak S. C., Love J. E., Jr Assays of serum lipase: analytical and clinical considerations. Clin Chem. 1986 Jul;32(7):1290–1302. [PubMed] [Google Scholar]
  8. Maxson C. J., Greenfield S. M., Turner J. L. Acute pancreatitis as a common complication of 2',3'-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol. 1992 Jun;87(6):708–713. [PubMed] [Google Scholar]
  9. Murthy U. K., DeGregorio F., Oates R. P., Blair D. C. Hyperamylasemia in patients with the acquired immunodeficiency syndrome. Am J Gastroenterol. 1992 Mar;87(3):332–336. [PubMed] [Google Scholar]
  10. Salt W. B., 2nd, Schenker S. Amylase--its clinical significance: a review of the literature. Medicine (Baltimore) 1976 Jul;55(4):269–289. doi: 10.1097/00005792-197607000-00001. [DOI] [PubMed] [Google Scholar]
  11. Tetrault G. A. Lipase activity in serum measured with Ektachem is often increased in nonpancreatic disorders. Clin Chem. 1991 Mar;37(3):447–451. [PubMed] [Google Scholar]
  12. Van Deun A., Cobbaert C., Van Orshoven A., Claeys G., Lissens W. Comparison of some recent methods for the differentiation of elevated serum amylase and the detection of macroamylasaemia. Ann Clin Biochem. 1989 Sep;26(Pt 5):422–426. doi: 10.1177/000456328902600508. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES